Sensei Biotherapeutics Stock Forward View - 8 Period Moving Average

SNSE Stock  USD 20.73  -2.67  -11.41%   
8 Period Moving Average is applied to Sensei Biotherapeutics's daily closing prices, and the resulting forecast is presented with accuracy metrics. Wide deviation between fitted and observed values suggests the model's assumptions may not match current market conditions. The 8 Period Moving Average model projects Sensei Biotherapeutics at 24.27 for the next trading day, above the most recent closing price. This 8 Period Moving Average output is provided as analytical reference and does not constitute a trading recommendation.
The eight-period moving average forecast for Sensei Biotherapeutics replaces each daily closing price with the mean of that value and the eight preceding observations. This wider window produces a smoother series that filters out short-term volatility.

8 Period Moving Average Price Forecast For the 12th of May 2026

Over a 90-day horizon, the 8 Period Moving Average model forecasts Sensei Biotherapeutics at 24.27 for the next trading day, with a mean absolute deviation of 2.00 , mean absolute percentage error of 0.07 , and sum of absolute errors of 106.17 .
This indicates moderate forecast accuracy — the model captures the general trend but not all short-term variation in Sensei Biotherapeutics' price. This output is intended for short-term analytical reference.

Stock Forecast Pattern

Backtest Sensei Biotherapeutics  Sensei Biotherapeutics Price Prediction  Research Analysis  

Forecasted Value

The projected range for Sensei Biotherapeutics reflects the model's ability to define credible downside and upside scenarios for the next trading day. Downside is estimated near 0.21 and upside near 48.63. The wide range indicates elevated uncertainty in short-term projections.
Market Value
20.73
24.27
Expected Value
48.63

Model Predictive Factors

The table below summarizes the 8 Period Moving Average model's error metrics for Sensei Biotherapeutics stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.
AICAkaike Information Criteria105.1938
BiasArithmetic mean of the errors 0.626
MADMean absolute deviation2.0032
MAPEMean absolute percentage error0.0719
SAESum of the absolute errors106.1675
The eight-period window effectively dampens daily peaks and troughs in Sensei Biotherapeutics price data, making the underlying trend more visible. However, the model can only be used reliably for one or two periods ahead. A flat forecast line in a trending market indicates the smoothing window is too wide for the current price dynamics.

Other Forecasting Options for Sensei Biotherapeutics

The distribution of Sensei Biotherapeutics' daily returns is typically non-normal, with fatter tails than a Gaussian model predicts. This reveals hidden support and resistance zones in Sensei Biotherapeutics' chart that simple price charts miss.

Sensei Biotherapeutics Related Equities

Investors studying Sensei Biotherapeutics often look at related stocks within the Health Care space to gauge pricing and results. Market cap and total value checks frame Sensei Biotherapeutics' size within the competitive field. When Sensei Biotherapeutics breaks from its peer group on a key metric, it often signals a firm-level change worth exploring.
 Risk & Return  Correlation

Sensei Biotherapeutics Market Strength Events

Market strength indicators for Sensei Biotherapeutics stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Sensei Biotherapeutics.

Sensei Biotherapeutics Risk Indicators

Assessing Sensei Biotherapeutics' risk indicators is a structured way to evaluate the risk-return trade-off for sensei stock. The level of risk embedded in Sensei Biotherapeutics' feeds directly into exposure calibration.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Sensei Biotherapeutics Short Properties

Reviewing short-oriented indicators for Sensei Biotherapeutics is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
Common Stock Shares Outstanding1.26 million
Cash And Short Term Investments21.18 million

More Resources for Sensei Stock Analysis

A clear view of Sensei Biotherapeutics comes from reviewing its financial structure and trends. The information reflects Sensei Biotherapeutics' most recent reporting inputs.